ENCAPIA 200mg tablets medication leaflet

N04BX02 entacapone • Nervous system | Dopaminergic agents | Other dopaminergic agents

Entacapone is a medication used in the treatment of Parkinson's disease, administered together with levodopa to increase its effectiveness. It works by inhibiting an enzyme that breaks down levodopa in the body, thus prolonging its effect and improving motor fluctuations in patients.

Entacapone is taken orally, usually with each dose of levodopa, as directed by your doctor. It is important for the patient to follow the treatment schedule and not to stop administration without medical advice.

Side effects may include diarrhea, nausea, reddish-brown urine discoloration, fatigue, or involuntary movements. Rarely, allergic reactions or liver disorders may occur. Regular medical monitoring is recommended during treatment.

Entacapone helps control the symptoms of Parkinson's disease and improve quality of life, but requires correct administration and medical supervision to prevent complications.

General data about ENCAPIA 200mg

Substance: entacapone

Date of last drug list: 01-06-2025

Commercial code: W59891002

Concentration: 200mg

Pharmaceutical form: tablets

Quantity: 60

Product type: generic

Price: 134.28 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: MEDOCHEMIE LTD. - CIPRU

Holder: MEDOCHEMIE LTD. - CIPRU

Number: 10628/2018/02

Shelf life: 2 years

Other substances similar to entacapone

Combinations with other substances

Compensation lists for ENCAPIA 200mg MEDOCHEMIE

G12 (C1) - Parkinson's disease

Price

Copayment

Patient

134.28 RON

134.28 RON

0.00 RON

GX (C1) - GENERIC (used in compensation list, C1, for another diagnosis)

Price

Copayment

Patient

134.28 RON

134.28 RON

0.00 RON